Documente Academic
Documente Profesional
Documente Cultură
DCF-13-2666B
DCF-13-2666B
Diabetes affects
1 in 12
People today
1 in 3
people by the year 2050
Test Strip
Share by Manufacturer*
Total Rx POS (%)
40.5%
19.2%
18.9%
OneTouch Ultra
Family of Products
New Product
Innovations
Sales Force
Strength
#1 Recommended
Brand by
Endocrinologists
Lowest Co-pay on
the Most Health
Plans*
Leading Share of
Voice in
Advertising
14.4%
5.7%
1.3%
LifeScan
Abbot
Abbott
Roche
Bayer
Private
Label
Other
Mfg
Source: TRx Share, Retail Sept YTD 2012. Data Source - IMS Xponent TRx Share.
*Some health plans may have more than one test strip covered at the lowest co-pay.
AW 3102280A
Test Strip
Share by Manufacturer*
Total Rx POS (%)
40.5%
19.2%
18.9%
OneTouch Ultra
Family of Products
New Product
Innovations
Sales Force
Strength
#1 Recommended
Brand by
Endocrinologists
Lowest Co-pay on
the Most Health
Plans*
Leading Share of
Voice in
Advertising
14.4%
5.7%
1.3%
LifeScan
Abbot
Abbott
Roche
Bayer
Private
Label
Other
Mfg
Source: TRx Share, Retail Sept YTD 2012. Data Source - IMS Xponent TRx Share.
*Some health plans may have more than one test strip covered at the lowest co-pay.
AW 3102280A
DCF-13-2666B
Rate of diabetes
diagnosis is
increasing
Chronic
disease
Co-morbid nature
of disease drives
additional needs
More
shoppers
Repeat
traffic
Higher basket
ring (front & back
of store).
Coverage Confusion
Commercial
Coverage
Medicare
Cost is a leading
reason why patients
stop testing
Retail
28%
Non-Retail
37%
Retail
11% Cash
27% Government
62% Commercial
Cash
35%
Mail Order
Mail Order
59% Government
41% Commercial
Data Source IMS DDD, 12 months ending June 12, Category size, mix, and share based on total test strip volume.
DCF-13-2666B
10
OneTouch
Commercial Coverage.
DCF-13-2666B
11
Formulary Misconceptions
500 Million
Operational inefficiencies
1National
12
Patients could
be saving up to:
$42/month
Data Source: Health Strategies Group: Health Plan Pharmacy Management Trends March 2013 data from 2012
DCF-13-2666B
13
2.
3.
NOTE: Not all members with a pharmacy benefit participate in this program.
*This is a case study of the United Healthcare Select Designated Pharmacy Program. This program is excluded in the following states: NY, NJ, CT, LA, AR,
and MD.
DCF-13-2666B
14
Opportunity to
convert
non-formulary
patients to
OneTouch.
1 Preferred:
2
For most plans, products that are usually covered at the lowest co-payment or co-insurance.
Plans that opt-in to the CVS Caremark 2014 Formulary Exclusion List.
The information provided is not a guarantee of coverage or payment. Actual benefits are determined by each plan in accordance with its
respective policies and procedures. All trademarks are the property of their respective owners.
DCF-13-2666B
15
Current Process
Patient presents
script to
Pharmacist/Tech
Prescription is
adjudicated and
processed
Patient receives
test strip
Future Process
Patient presents script
to Pharmacist/Tech
Insurance coverage is
checked to determine
lowest copay
Prescription is
adjudicated and
processed
16
DCF-13-2666B
17
OneTouch
Medicare Coverage.
DCF-13-2666B
18
Coverage Confusion
Commercial
Coverage
Medicare
Cost is a leading
reason why patients
stop testing
19
80%
Medicare
DME: Durable Medical Equipment
With Medicare Part B and most
supplemental insurance plans,
patients will have
$0
out-of-pocket
20%
Supplemental
(MediGap)
Not a guarantee of coverage and payment. Coverage and payment may be subject to co-insurance, deductible and patient eligibility requirements
DCF-13-2666B
20
Medicare Challenges
Coverage changes causing confusion and shift to mail order
Coverage Confusion
What is covered?
Where can I get my favorite brand?
More convenient
*Not a guarantee of coverage and payment. Coverage and payment may be subject to co-insurance, deductible and patient eligibility requirements.
Data Source: Roper Patient Data 2010
DCF-13-2666B
21
1Applicable
22